文献速递腹部MR

肝细胞腺瘤更新:诊断、分子分型与临床病程

Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course.
PubMed 文献 · Br J Radiol · 2024-01-01

肝细胞腺瘤多见于长期使用含雌激素避孕药的年轻至中年女性或长期使用合成代谢类固醇的年轻男性,肥胖、代谢功能障碍相关脂肪性肝病、糖原贮积病等也是危险因素。2017年波尔多分类基于表型和基因型将肝细胞腺瘤分为八个亚型,其中三个亚型为高风险病变,需适当管理;男性任何肝细胞腺瘤或直径超过5 cm者推荐择期手术。MRI可对高达80%的腺瘤进行分型,若结果不明确,活检仍是腺瘤亚型的参考标准。

要点

  • 肝细胞腺瘤八个亚型中三个为高风险病变,需适当管理。
  • 男性任何肝细胞腺瘤或直径超过5 cm者推荐择期手术。
  • MRI可对高达80%的腺瘤进行分型,结果不明确时活检为参考标准。

核心结论

  • 肝细胞腺瘤不应再未经组织学检查即视为纯良性,八个亚型中三个为高风险病变需适当管理;男性任何肝细胞腺瘤或直径超过5 cm者推荐择期手术;MRI可对高达80%的腺瘤进行分型,结果不明确时活检为亚型参考标准。

研究设计与样本

  • 综述,基于2017年波尔多分类(尤其Nault等)按表型和基因型特征将肝细胞腺瘤分为八个亚型,未报告系统检索范围与纳入文献数量。

诊断标准与关键数值

  • 2017年波尔多分类将肝细胞腺瘤分为八个亚型,包括肝细胞核因子1α突变型、β-catenin突变型以及无上述两种基因突变的亚型(进一步分为有和无炎症细胞);MRI可对高达80%的腺瘤进行分型。

临床应用与阅片要点

  • 男性任何肝细胞腺瘤或直径超过5 cm者推荐择期手术;MRI可对高达80%的腺瘤进行分型,若结果不明确,活检仍是腺瘤亚型的参考标准。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular adenomas (HCA) are acquired focal liver lesions, that occur mainly in young-to-middle-aged women who are on long-term estrogen-containing contraceptives or young men after prolonged use of anabolic steroids. Furthermore, distinct underlying diseases, such as obesity, metabolic dysfunction-associated steatotic liver disease, glycogen storage disease, etc. are considered risk factors. The 2017 Bordeaux classification, in particular Nault et al, divided HCAs into eight subtypes according to their pheno- and genotypic characteristics. This includes HCAs with hepatocyte-nuclear-factor (HNF1-alpha mutation), HCAs with β-catenin mutation, and HCAs without either of these genetic mutations, which are further subdivided into HCAs with and without inflammatory cells. HCAs should no longer be classified as purely benign without histologic workup since three of the eight subtypes are considered high-risk lesions, requiring adequate management: malignant transformation of the pure (ßex3-HCA) and mixed inflammatory/β-catenin exon 3 (ßex3-IHCA) adenomas, as well as potential bleeding of the sonic hedgehog HCA and pure (ßex7/8-HCA) and mixed inflammatory/β-catenin exon 7/8 (ßex7/8-IHCA). Elective surgery is recommended for any HCA in a male, or for any HCA exceeding 5 cm. Although MRI can classify up to 80% of adenomas, if findings are equivocal, biopsy remains the reference standard for adenoma subtype.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Poetter-Lang S, Ba-Ssalamah A, Bastati N, et al. Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course. Br J Radiol. 2024. PMID: 39235933. doi:10.1093/bjr/tqae180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。